相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Precision dosing of warfarin: open questions and strategies
Xi Li et al.
PHARMACOGENOMICS JOURNAL (2019)
Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement-a hybrid model with genetic algorithm and Back-Propagation neural network
Qian Li et al.
SCIENTIFIC REPORTS (2018)
Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose
Zhiyuan Ma et al.
PLOS ONE (2018)
Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System
Dong-Jin Kim et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2017)
Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C Carriers
Mina Yang et al.
CLINICAL THERAPEUTICS (2016)
Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients
Sun-Mi Cho et al.
YONSEI MEDICAL JOURNAL (2016)
Revisiting Warfarin Dosing Using Machine Learning Techniques
Ashkan Sharabiani et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2015)
Characterizing variability in warfarin dose requirements in children using modelling and simulation
Anna-Karin Hamberg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms
Michela Cini et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients
Jung Ran Choi et al.
JOURNAL OF HUMAN GENETICS (2011)
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Mark H. Eckman et al.
ANNALS OF INTERNAL MEDICINE (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement
Ho-Sook Kim et al.
PHARMACOGENETICS AND GENOMICS (2009)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
David A. Flockhart et al.
GENETICS IN MEDICINE (2008)
Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients
Kenji Nakai et al.
PHARMACOGENOMICS (2007)
Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients
Hyun-Jung Cho et al.
PHARMACOGENOMICS (2007)
Pharmacogenetics of warfarin: current status and future challenges
M. Wadelius et al.
PHARMACOGENOMICS JOURNAL (2007)
Association of warfarin dose with genes involved in its action and metabolism
Mia Wadelius et al.
HUMAN GENETICS (2007)
VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients
Kyoko Obayashi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Warfarin and its interactions with foods, herbs and other dietary supplements
Edith A. Nutescu et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population
SC Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population
DL Veenstra et al.
PHARMACOGENETICS AND GENOMICS (2005)
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements:: proposal for a new dosing regimen
EA Sconce et al.
BLOOD (2005)
Allele and genotype frequencies of CYP2C9 in a Korean population
JW Bae et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
G D'Andrea et al.
BLOOD (2005)
Limitations of ordinary least squares models in analyzing repeated measures data
C Ugrinowitsch et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2004)
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
BF Gage et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin
H Takahashi et al.
PHARMACOGENOMICS JOURNAL (2003)
Interindividual variability in sensitivity to warfarin - Nature or nurture?
R Loebstein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
分享论文
